Verifying…
Home / Drug A–Z / Epiflin 1 mg Gel

Epiflin 1 mg Gel

NAFDAC Reg. No. A4-101036 · Drug

Registered with NAFDAC — registration activeAs of 6 November 2026 · synced automatically from official sources.
Product
Epiflin 1 mg Gel
NAFDAC number
A4-101036
Active ingredient
Adapalene
Strength
0.1%
Form
Gel
Pack size
15 g tube
Manufacturer
Not listed
Applicant (holder)
Akso Pharmaceutical Nigeria Limited
Approved
25 Sep 2024
Status
Active View on NAFDAC ↗
Registration valid to
24 Sep 2029
WHO alerts
None found
Community reports
None
Times checked
0

RxVerify commentary

  • Epiflin 1 mg Gel is on the NAFDAC register with an active registration (A4-101036). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. Not medical advice — always follow your doctor or pharmacist.

What Epiflin 1 mg Gel is used for

From the official U.S. FDA label for adapalene, the active ingredient registered with NAFDAC.

What it is used for

For the treatment of acne

Purpose

Acne treatment

Possible side effects

▪ you become pregnant, or are planning to become pregnant while using the product ▪ you have symptoms of an allergic reaction (such as itching, rash, hives, swelling of the lips, eyelids, and shortness of breath) ▪ irritation becomes severe ▪ you see no improvement after 3 months of once daily use

Do not use if

▪on damaged skin (cuts, abrasions, eczema, sunburn) ▪ if you are allergic to adapalene or any of the ingredients in this product

Warnings

For external use only Do not use ▪on damaged skin (cuts, abrasions, eczema, sunburn) ▪ if you are allergic to adapalene or any of the ingredients in this product If pregnant or breast-feeding, ask a doctor before use. When using this product ▪ limit sun exposure, including light from tanning beds, and use sunscreen when going outdoors. ▪ do not wax to remove hair in areas where the product has been applied ▪ during the early weeks of use, your acne may appear to worsen before it improves (this is normal); continue using as directed, unless you get irritation that becomes severe ▪ irritation (redness, itching, dryness, burning) is more likely to occur: ▪ in the first few weeks of use ▪ if usi …

Pregnancy & breastfeeding

If pregnant or breast-feeding, ask a doctor before use.

Storage

▪ store at room temperature 68° to 77°F ▪ protect from freezing

General information only — not dosing advice. Always follow the leaflet in your pack and your doctor or pharmacist.

Check your pack of Epiflin 1 mg Gel

Add the expiry date printed on your pack for a full Trust Score — or look up uses, side effects and cheaper generics.

3 free checks left today · no signup Official sources: NAFDAC Green Book & recalls · WHO · U.S. FDA · NLM RxNorm

About Epiflin 1 mg Gel

What is in Epiflin 1 mg Gel?

Epiflin 1 mg Gel contains Adapalene (0.1%), as gel, according to its NAFDAC registration record.

Is Epiflin 1 mg Gel registered with NAFDAC?

Yes. Epiflin 1 mg Gel is listed on the NAFDAC register under registration number A4-101036, and its registration is active as of 6 November 2026.

Has Epiflin 1 mg Gel been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Epiflin 1 mg Gel in our automatically synced alert list.

How can I check that my pack of Epiflin 1 mg Gel is genuine?

Run a free authenticity scan with the NAFDAC number A4-101036, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

What is Epiflin 1 mg Gel used for?

For the treatment of acne (Summarised from the official U.S. FDA label for adapalene. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Epiflin 1 mg Gel? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from RxVerify users, not medical advice. Report side effects to your doctor and to NAFDAC.